ArticleNature communications2026
Flow-mediated endothelial remodeling and inflammation drive developmental vascular susceptibility in ldlr loss of function.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Atherosclerosis, the leading cause of cardiovascular disease, is associated with aberrant lipid metabolism, endothelial dysfunction, and chronic inflammation, yet its early manifestations and mechanisms remain incompletely understood. As low-density lipoprotein receptor loss of function is the most common monogenic cause of atherosclerosis, we employed low-density lipoprotein receptor knockout (ldlr-/-) zebrafish to investigate the developmental origins of atherosclerotic cardiovascular disease. Single-cell RNA-sequencing under differential flow conditions in embryonic ldlr-/- zebrafish identified a population of disproportionately stressed endothelial cells marked by overexpression of heat shock protein 70 (hsp70). Hsp70 is induced in stressed endothelial cells in a flow-dependent manner in zebrafish and a subset of human endothelial cells, and its activation is associated with disrupted remodeling angiogenesis in vivo. Genetic and pharmacological studies demonstrated that hsp70 upregulation inhibits vascular apoptosis and ciliogenesis, leading to altered angiogenic remodeling. Concurrently, pro-inflammatory processes, including enhanced myelopoiesis and thrombogenicity, are amplified at early stages in ldlr-/- zebrafish, which also exhibit impaired regenerative angiogenesis and heightened neutrophil recruitment post-vascular injury. Our findings reveal how abnormalities in flow-mediated endothelial remodeling and inflammation converge during embryogenesis to drive vascular susceptibility to hemodynamic and other stressors in ldlr loss of function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.